Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Completed
NCT01944800
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome
4,018
Enrollment(s)
19
Study location(s)
Interventional (Phase IV)
Acute Coronary Syndrome (ACS)
Completed
NCT03882177
StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis
35
Enrollment(s)
1
Study location(s)
Interventional (Phase II)
Tuberculosis
Pulmonary Tuberculosis
Recruiting
NCT04257162
HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a)
180
Enrollment(s)
15
Study location(s)
Interventional (Not Applicable)
Metastatic Cancer
Completed
NCT04796831
A Study to Determine the Absolute Oral Bioavailability of Quizartinib Using a Radiolabeled Microtracer in Healthy Subjects
8
Enrollment(s)
1
Study location(s)
Interventional (Phase I)
Healthy Subjects
Recruiting
NCT04297150
Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..
700
Enrollment(s)
6
Study location(s)
Observational
Atrial Fibrillation
Completed
NCT03757481
Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE
156
Enrollment(s)
11
Study location(s)
Interventional (Not Applicable)
Post Thrombotic Syndrome
Deep Vein Thrombosis
Chronic Thromboembolic Pulmonary Hypertension
Not yet recruiting
NCT04684212
Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF
3,181
Enrollment(s)
1
Study location(s)
Interventional (Not Applicable)
Atrial Fibrillation
Left Atrial Appendage Thrombosis
CVA
Recruiting
NCT05152420
Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects
128
Enrollment(s)
1
Study location(s)
Interventional (Phase I)
Coagulation Disorder
31
32
33
34
35